BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28400314)

  • 1. PEG-PE/clay composite carriers for doxorubicin: Effect of composite structure on release, cell interaction and cytotoxicity.
    Kohay H; Sarisozen C; Sawant R; Jhaveri A; Torchilin VP; Mishael YG
    Acta Biomater; 2017 Jun; 55():443-454. PubMed ID: 28400314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
    Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
    Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles of pH-Responsive, PEG-Doxorubicin Conjugates: Interaction with an in Vitro Model of Lung Adenocarcinoma and Their Direct Formulation in Propellant-Based Portable Inhalers.
    Rao KSVK; Zhong Q; Bielski ER; da Rocha SRP
    Mol Pharm; 2017 Nov; 14(11):3866-3878. PubMed ID: 28972765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice.
    Wei X; Wang Y; Zeng W; Huang F; Qin L; Zhang C; Liang W
    Pharm Res; 2012 Jul; 29(7):1977-89. PubMed ID: 22426964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
    Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
    Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
    Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
    Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
    Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
    J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity.
    Song YF; Liu DZ; Cheng Y; Liu M; Ye WL; Zhang BL; Liu XY; Zhou SY
    Sci Rep; 2015 Nov; 5():16125. PubMed ID: 26530454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin encapsulated in micelles enhances radiosensitivity in doxorubicin-resistant tumor cells.
    Xu W; Han M; Diao Y; Pan T; Ge W; Liu H; He H; Jiang H; Zheng S; Zhang S; Gao J; Wei Q
    Discov Med; 2014 Oct; 18(99):169-77. PubMed ID: 25336030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin.
    Tang N; Du G; Wang N; Liu C; Hang H; Liang W
    J Natl Cancer Inst; 2007 Jul; 99(13):1004-15. PubMed ID: 17596572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
    Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
    Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
    Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
    Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Responsive chimaeric pepsomes based on asymmetric poly(ethylene glycol)-b-poly(l-leucine)-b-poly(l-glutamic acid) triblock copolymer for efficient loading and active intracellular delivery of doxorubicin hydrochloride.
    Chen P; Qiu M; Deng C; Meng F; Zhang J; Cheng R; Zhong Z
    Biomacromolecules; 2015 Apr; 16(4):1322-30. PubMed ID: 25759951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes.
    Petrini M; Lokerse WJM; Mach A; Hossann M; Merkel OM; Lindner LH
    Int J Nanomedicine; 2021; 16():4045-4061. PubMed ID: 34163158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.